Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Therapie
|
August 9, 2011
[Evidence-based therapeutic drug monitoring for efavirenz]
Caroline Solas, Marie-Claude Gagnieu,
Therapie
|
July 10, 2016
[Not Available]
Caroline Solas, Marie-Claude Gagnieu,
Practical Laboratory Medicine
|
September 1, 2017
The Roche Total Mycophenolic Acid® assay: An application protocol for the ABX Pentra 400 analyzer and comparison with LC-MS in children with idiopathic nephrotic syndrome
François Parant, Bruno Ranchin, Marie-Claude Gagnieu
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 15, 2007
Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring
Mirna El Barkil, Marie-Claude Gagnieu, Jérôme Guitton
Journal of Hepatology
|
May 19, 2007
Ribavirin in combination therapy for HCV chronic infection in HIV patients: how to win the war after winning the first battle?
Claude Souvignet, Marianne Maynard, Marie-Claude Gagnieu, et al.
Therapeutic Drug Monitoring
|
March 1, 2019
Dolutegravir Population Pharmacokinetics in a Real-Life Cohort of People Living With HIV Infection: A Covariate Analysis
François Parant, Patrick Miailhes, Florence Brunel, et al.
Therapeutic Drug Monitoring
|
July 27, 2005
Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA)
François Parant, Mustapha Moulsma, Marie Claude Gagnieu, et al.
Current Drug Safety
|
January 19, 2018
Dolutegravir-Related Neurological Adverse Events: A Case Report of Successful Management with Therapeutic Drug Monitoring
Francois Parant, Patrick Miailhes, Florence Brunel, et al.
Therapeutic Drug Monitoring
|
November 25, 2005
No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir: a population approach
Eric Dailly, Marie-Claude Gagnieu, Clotilde Allavena, et al.
Antiviral Therapy
|
August 5, 2008
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients
Marianne Maynard, Pierre Pradat, Marie-Claude Gagnieu, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Therapie
|
August 9, 2011
[Evidence-based therapeutic drug monitoring for efavirenz]
Caroline Solas, Marie-Claude Gagnieu,
Therapie
|
July 10, 2016
[Not Available]
Caroline Solas, Marie-Claude Gagnieu,
Practical Laboratory Medicine
|
September 1, 2017
The Roche Total Mycophenolic Acid® assay: An application protocol for the ABX Pentra 400 analyzer and comparison with LC-MS in children with idiopathic nephrotic syndrome
François Parant, Bruno Ranchin, Marie-Claude Gagnieu
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 15, 2007
Relevance of a combined UV and single mass spectrometry detection for the determination of tenofovir in human plasma by HPLC in therapeutic drug monitoring
Mirna El Barkil, Marie-Claude Gagnieu, Jérôme Guitton
Journal of Hepatology
|
May 19, 2007
Ribavirin in combination therapy for HCV chronic infection in HIV patients: how to win the war after winning the first battle?
Claude Souvignet, Marianne Maynard, Marie-Claude Gagnieu, et al.
Therapeutic Drug Monitoring
|
March 1, 2019
Dolutegravir Population Pharmacokinetics in a Real-Life Cohort of People Living With HIV Infection: A Covariate Analysis
François Parant, Patrick Miailhes, Florence Brunel, et al.
Therapeutic Drug Monitoring
|
July 27, 2005
Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA)
François Parant, Mustapha Moulsma, Marie Claude Gagnieu, et al.
Current Drug Safety
|
January 19, 2018
Dolutegravir-Related Neurological Adverse Events: A Case Report of Successful Management with Therapeutic Drug Monitoring
Francois Parant, Patrick Miailhes, Florence Brunel, et al.
Therapeutic Drug Monitoring
|
November 25, 2005
No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir: a population approach
Eric Dailly, Marie-Claude Gagnieu, Clotilde Allavena, et al.
Antiviral Therapy
|
August 5, 2008
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients
Marianne Maynard, Pierre Pradat, Marie-Claude Gagnieu, et al.
Page
of 7